pharma news today obesity drugs glp-1 september 2025 medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during pregnancy or while nursing. The current recommendation is to stop before conception and discuss FDA takes aim at telehealth
Description
The incidence of diabetes is on the rise with 11.3 percent of the US population (37.3 million or roughly one in ten Americans) currently having the condition

Speak to a weight loss specialist by contacting a clinic in your community

Very rare cases of intestinal obstruction have been reported which can be a serious health problem that requires surgery

Therefore, after successful phase III studies, 3 mg liraglutide was approved for obesity therapy [38]

Matz tailors GLP-1 therapy to each patients unique needs, ensuring that it works effectively as part of a comprehensive weight loss plan
*Correspondence: Youxin Chen, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
